PCSK9 inhibitors for prevention of cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PCSK9 Inhibitors for Prevention of Cardiovascular Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/_________PCSK9_inhibitors_for_prevention_of_cardiovascular_disease______.
PCSK9 inhibitors for prevention of cardiovascular disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/_________PCSK9_inhibitors_for_prevention_of_cardiovascular_disease______. Accessed March 15, 2025.
PCSK9 inhibitors for prevention of cardiovascular disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/_________PCSK9_inhibitors_for_prevention_of_cardiovascular_disease______
PCSK9 Inhibitors for Prevention of Cardiovascular Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/_________PCSK9_inhibitors_for_prevention_of_cardiovascular_disease______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PCSK9 inhibitors for prevention of cardiovascular disease
ID - 1305377
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305377/all/_________PCSK9_inhibitors_for_prevention_of_cardiovascular_disease______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -